Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

dc.contributor.author	Gouglas, Dimitrios
dc.contributor.author	Le, Tung Thanh
dc.contributor.author	Henderson, Klara
dc.contributor.author	Kaloudis, Aris
dc.contributor.author	Danielsen, Trygve
dc.contributor.author	Hammersland, Nicholas Carspersen
dc.contributor.author	Robinson, James M.
dc.contributor.author	Heaton, Penny M.
dc.contributor.author	Røttingen, John-Arne
dc.date.accessioned	2022-07-25T13:04:03Z
dc.date.available	2022-07-25T13:04:03Z
dc.date.created	2018-10-18T14:39:22Z
dc.date.issued	2018
dc.identifier.citation	The Lancet Global Health. 2018, 6 (12), e1386-e1396.
dc.identifier.issn	2214-109X
dc.identifier.uri	https://hdl.handle.net/11250/3008230
dc.language.iso	eng
dc.title	Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.pagenumber	e1386-e1396
dc.source.volume	6
dc.source.journal	The Lancet Global Health
dc.source.issue	12
dc.identifier.doi	10.1016/S2214-109X(18)30346-2
dc.identifier.cristin	1621448
cristin.unitcode	7502,2,0,0
cristin.unitname	Instituttledelse
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1